Genome Biologics Our Technology Articles & Analysis: Older
15 articles found
Genome editing, a transformative technology in genetic research, has revolutionized the way scientists study and modify plant genomes. Among the most prominent methods utilized in recent years, CRISPR-Cas9 has emerged as a breakthrough tool that allows for precise and targeted modifications. Model plants, often employed due to their well-characterized genomes and simple genetics, serve as ideal ...
Understanding Knockin Cell Line Generation At its core, knockin cell line generation utilizes sophisticated gene-editing technologies, such as CRISPR-Cas9, to facilitate precise genomic integration. ...
Next-Generation Sequencing (NGS) has revolutionized genomics, providing unprecedented insights into the structure and function of genomes, transcriptomes, and epigenomes. A critical step in the NGS workflow is library preparation, which involves converting DNA or RNA samples into a form that can be sequenced. NGS Library Preparation Kits play a pivotal role in this process, ensuring high-quality ...
Additionally, the employment of cutting-edge technologies, like next-generation sequencing (NGS), furthers the scope of zebrafish genome editing services. ...
Genomic engineering in cell lines is a versatile tool for studying gene function, designing diseases models, biopharmaceutical research, drug discovery and many other applications. CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats)/Cas9 systems is a newly developed yet the most popular method for genome editing. It has been widely used in current biology, functional genome ...
Oxford Nanopore Technologies (ONT) sequencing has witnessed significant progress in recent years, becoming a key player in the genomics field. As the technology matures, so does the bioinformatics analysis of ONT data. Researchers have been diligently developing specialized tools and algorithms to better utilize the unique characteristics of ONT data, such as long read lengths and ionic current ...
CD Genomics, a well-established leader in transcriptome solutions, is pleased to announce the introduction of Ribosome Profiling technology. ...
Additionally, the employment of cutting-edge technologies, like next-generation sequencing (NGS), furthers the scope of zebrafish genome editing services. ...
What is pan-genome? A pan-genome is the sum of all genomic information within a species. With the development of genomic technology, researchers have found that a single reference genome can no longer meet the needs of genomic data analysis, and more and more species, including the human genome, are choosing to construct a pan-genome instead of a single reference genome. Pan-genomes reflect ...
Whole genome sequencing technology can comprehensively and accurately analyze entire genomes, thereby breaking the information contained in it and revealing the complexity and diversity of the genome. The emergence of whole genome sequencing technology is a revolutionary advancement in all areas ...
Each year malaria kills hundreds of thousands of people – mostly children – around the globe, and according to a report by the WHO, in 2021 nearly half of the world’s population was at risk of malaria. This included infants, children under 5 years of age, pregnant women, patients with HIV/AIDS, etc. Moreover, over the two peak years of the pandemic, COVID-related disruptions ...
The high-throughput detection of gene expression relies on next generation sequencing technologies to assess the level of expression of all genes in the genome. These technologies have revolutionized transcriptomic research and we are now entering the ultra-high-throughput era of gene expression studies. ...
Although humans and zebrafish have distinct appearances, they possess more than 70% of the same genes at the genomic level. This genomic similarity allows researchers to better understand the biology of zebrafish cell regeneration before translating the findings into humans. ...
The Clinical CRISPR Successes Are Stacking Up. But Where’s the Emphasis on Quality Control? In mid-September, Intellia released some promising data on two of their CRISPR-based therapeutics. These results are a significant milestone for genome editing and validation of its effectiveness in the clinic. However, the safety of CRISPR-based therapeutics has been a major concern and part of a ...
CAMBRIDGE, MA--(Marketwired - Jun 30, 2015) - Nuclea Biotechnologies Inc. announced today that it is partnering with Aelan Cell Technologies Inc. (San Francisco, California) for the development, validation and commercialization of novel biomarker tests and companion diagnostics using human STEM cells as models. Their collaboration has the potential to impact disease monitoring and drug ...